4
Changes in Ownership
PMV Pharmaceuticals, Inc. Filed Acc 0001209191-21-030096
COO, CFO sold 4,500 shares at $33.75 ($151,875)
- COO, CFO acquired 4,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kung Winston COO, CFO | 2021-05-03 | Option exercise | +4,500 | $3.22 | $14,490 | 6,100 | D: show line 1 in the form |
| Kung Winston COO, CFO | 2021-05-03 | Sale | −4,500 | $33.75 | $151,875 | 1,600 | D: show line 2 in the form |
| Open-market sales · 4,500 sh · avg $33.75 · $151,875 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Kung Winston COO, CFO | 2021-05-03 | Option exercise · Stock Option (right to buy) | −4,500 | 232,534 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…